TriSalus Life Sciences reaffirms $60M–$62M revenue guidance for 2026 while expanding PEDD portfolio
TriSalus Life Sciences, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.67
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS